No phaseRecruiting

The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults (ATLAS 2)

A Confirmatory, Randomised, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Effects of a Dietary Supplement Containing Urolithin A (Mitopure®) on Muscle Strength and Performance in Healthy Middle-Aged Adults

Sponsor
Amazentis SA (Industry)
Enrolment
120 planned
Conditions
Healthy Aging; Muscle Function
Interventions
Placebo; Mitopure® 500mg; Mitopure® 1000mg
Ages
adults, older adults
Registry
NCT07231783

From the registry

This is a randomised, double-blind, placebo-controlled, parallel study to assess the effects of Urolithin A (Mitopure®) supplementation on muscle strength and performance in healthy middle-aged adults. Participants will be randomized to consume Mitopure® (500 mg), Mitopure® (1000 mg), or placebo once daily for 6 months.

Primary outcomes

  • Maximum isokinetic knee flexion strength
Full record on ClinicalTrials.gov